bioAffinity Technologies (BIAFW) Competitors $0.10 0.00 (-1.19%) As of 08/18/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock BIAFW vs. ADVWW, MMA, AUUDW, BAOS, CFFEW, CTK, CTW, DKDCW, DTSTW, and ESGLWShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include Advantage Solutions (ADVWW), Alta Global Group (MMA), Auddia (AUUDW), Baosheng Media Group (BAOS), CF Acquisition Corp. VIII (CFFEW), CooTek (Cayman) (CTK), CTW Cayman (CTW), Data Knights Acquisition (DKDCW), Data Storage (DTSTW), and ESGL (ESGLW). These companies are all part of the "business services" industry. bioAffinity Technologies vs. Its Competitors Advantage Solutions Alta Global Group Auddia Baosheng Media Group CF Acquisition Corp. VIII CooTek (Cayman) CTW Cayman Data Knights Acquisition Data Storage ESGL bioAffinity Technologies (NASDAQ:BIAFW) and Advantage Solutions (NASDAQ:ADVWW) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment. Does the media refer more to BIAFW or ADVWW? In the previous week, bioAffinity Technologies had 1 more articles in the media than Advantage Solutions. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for Advantage Solutions. bioAffinity Technologies' average media sentiment score of 0.38 beat Advantage Solutions' score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the media. Company Overall Sentiment bioAffinity Technologies Neutral Advantage Solutions Neutral Which has higher valuation & earnings, BIAFW or ADVWW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobioAffinity Technologies$8.81MN/AN/AN/AN/AAdvantage Solutions$3.53BN/AN/AN/AN/A Is BIAFW or ADVWW more profitable? Company Net Margins Return on Equity Return on Assets bioAffinity TechnologiesN/A N/A N/A Advantage Solutions N/A N/A N/A SummarybioAffinity Technologies beats Advantage Solutions on 2 of the 3 factors compared between the two stocks. Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAFW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIAFW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAFW vs. The Competition Export to ExcelMetricbioAffinity TechnologiesDiagnostics & Research IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$989.50M$5.73B$9.80BDividend YieldN/A5.44%4.54%4.09%P/E RatioN/A2.2830.7325.12Price / SalesN/A471.44419.4799.72Price / CashN/A11.4237.3459.16Price / BookN/A2.658.886.24Net IncomeN/A$334.07B$3.26B$265.56M7 Day PerformanceN/A6.18%-0.41%-0.74%1 Month PerformanceN/A5.15%3.54%1.95%1 Year PerformanceN/A2.57%28.53%21.14% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFWbioAffinity TechnologiesN/A$0.10-1.2%N/A-94.6%$0.00$8.81M0.0010Gap DownADVWWAdvantage SolutionsN/A$0.01-1.1%N/A-47.6%$0.00$3.53B0.0075,000MMAAlta Global GroupN/A$0.86-2.2%N/A-69.9%$0.00$562.31K0.00N/AGap DownAUUDWAuddiaN/A$0.02-30.8%N/A-22.0%$0.00N/A0.0020High Trading VolumeBAOSBaosheng Media Group0.5723 of 5 stars$2.74-0.1%N/A+35.0%$0.00$620K0.00130Short Interest ↑CFFEWCF Acquisition Corp. VIIIN/A$0.03flatN/A-72.6%$0.00N/A0.003Gap UpCTKCooTek (Cayman)N/A$0.01-43.5%N/A-69.4%$0.00$30.32M0.00380Gap UpHigh Trading VolumeCTWCTW CaymanN/A$2.01+7.5%N/AN/A$0.00$76.19M0.00272Gap DownDKDCWData Knights AcquisitionN/A$0.02-37.5%N/A-8.6%$0.00N/A0.002Gap DownDTSTWData StorageN/A$0.28-5.0%N/A-54.8%$0.00$25.22M0.0060Gap DownHigh Trading VolumeESGLWESGLN/A$0.07+0.1%N/AN/A$0.00$6.10M0.00N/A Related Companies and Tools Related Companies ADVWW Competitors MMA Competitors AUUDW Competitors BAOS Competitors CFFEW Competitors CTK Competitors CTW Competitors DKDCW Competitors DTSTW Competitors ESGLW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIAFW) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access